Summary
A 25-year-old defense contractor was denied a security clearance under Guideline H (Drug Involvement) due to a significant and unresolved history of illegal drug use. The applicant admitted to using marijuana, cocaine, and hallucinogenic acid, and expressed an intent to continue using marijuana.
Specifically, the applicant began using marijuana in November 2012 as a college sophomore, continuing at least monthly until March 2017, two years into his defense contractor employment. He also admitted to using cocaine twice, once in 2012 and again in 2015, and hallucinogenic acid on one occasion in approximately June 2016. A key factor in the denial was his stated intent to continue marijuana use.
The judge found that the applicant's admitted history of illegal drug use, coupled with his intent to continue marijuana use and maintained social ties with past drug-using associates, raised significant security concerns. The applicant failed to provide mitigating evidence, such as character references or proof of rehabilitation, leading to the denial of national security eligibility.
Why the Applicant Was Denied
- The applicant admitted to a history of illegal drug use, including marijuana, cocaine, and hallucinogenic acid.
- The applicant expressed an intent to continue marijuana use and maintained social ties with past drug-using associates.
- The applicant failed to provide mitigating evidence, such as character references or proof of rehabilitation.
Conditions Referenced
- AG ¶ 25(a)raisedSubstance Misuse
- AG ¶ 25(c)raisedIllegal Possession of a Controlled Substance
- AG ¶ 25(g)raisedIntent to Continue Drug Involvement
Key Rule Quoted
“The protection of the national security is the paramount consideration.”
Procedural Posture
- SOR issuedAug 4, 2017
- Answer filedAug 21, 2017
- Hearing held—Applicant requested decision on written record.
- Decision dateDec 26, 2018
Cite For
- Denial of Security Clearance Due to Unresolved Drug Use History
- Significance of Intent to Continue Drug Use in Security Clearance Evaluations
- Lack of Mitigating Evidence in Drug Involvement Cases